glp 1 for ankylosing spondylitis GLP-1 coverage spondylitis? GLP-1 Agonists In Arthritis And
Description
Orskov C, and Poulsen SS

Wang T, Hong JL, Gower EW, et al

Nature medicine , 28 (10), 2083-2091

Novo Nordisk's semaglutide beats its counterpart liraglutide to become the next generation of weight loss innovation, and then Eli Lilly's GLP-1R/GIPR dual-target agonist tirzepatide achieves a 22.5% weight loss, surpassing semaglutide's weight loss history

Those with specific contraindications: Personal or family history of medullary thyroid carcinoma or MEN2 syndrome, history of pancreatitis
